Open access
112
Views
7
CrossRef citations to date
0
Altmetric
Original Research
Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease
Teddy Kosoglou1 Clinical Pharmacology, Merck Sharp & Dohme Corp, Whitehouse Station, NJ, USACorrespondence[email protected]
, James Hubbell2 Exploratory Drug Metabolism, Merck Sharp & Dohme Corp, Whitehouse Station, NJ, USA
, Fengjuan Xuan3 Early Development Statistics, Merck Sharp & Dohme Corp, Whitehouse Station, NJ, USA
, David L Cutler1 Clinical Pharmacology, Merck Sharp & Dohme Corp, Whitehouse Station, NJ, USA
, Alan G Meehan4 Medical Communications, Merck Sharp & Dohme Corp, Whitehouse Station, NJ, USA
, Bhavna Kantesaria5 Drug Metabolism/Pharmacokinetics, Merck Sharp & Dohme Corp, Whitehouse Station, NJ, USA
& Bret A Wittmer6 Commonwealth Biomedical Research, LLC, Madisonville, KY, USA
show all
Pages 107-116
|
Published online: 04 Mar 2013
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.